APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peptide Therapeutics Drugs Industry Growth and Trends Forecast to 2032

23 December 2025112 pages

Choose your research edition.

Industry ResearchPeptide Therapeutics Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Therapeutics Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Peptide Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Therapeutics Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Therapeutics Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Peptide Therapeutics Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peptide Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peptide Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Peptide Therapeutics Drugs market include Takeda, Teva, Sanofi, J & J, Novartis, Novo Nordisk, Merck, Eli Lilly and Ferring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peptide Therapeutics Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptide Therapeutics Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Therapeutics Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Therapeutics Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Peptide Therapeutics Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptide Therapeutics Drugs Market by Company

Takeda

Teva

Sanofi

J & J

Novartis

Novo Nordisk

Merck

Eli Lilly

Ferring

AbbVie

AstraZeneca

The Medicines

Lantheus

Ipsen

CSL Vifor Group

BioMarin Pharmaceutical

Aurinia Pharmaceuticals

Apellis Pharmaceuticals

Peptide Therapeutics Drugs Segment by Type

Injection

Oral

Other

Peptide Therapeutics Drugs Segment by Application

Central Nervous System

Metabolic Disorders

Cancer

Other

Peptide Therapeutics Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Peptide Therapeutics Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Therapeutics Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Peptide Therapeutics Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Peptide Therapeutics Drugs Market Share by Region (2021-2026) Table 4. Global Peptide Therapeutics Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Peptide Therapeutics Drugs Market Share by Region (2027-2032) Table 6. Global Peptide Therapeutics Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Peptide Therapeutics Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Peptide Therapeutics Drugs Market Size Share by Type (2021-2026) Table 9. Global Peptide Therapeutics Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Peptide Therapeutics Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Peptide Therapeutics Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Peptide Therapeutics Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Peptide Therapeutics Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Peptide Therapeutics Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Peptide Therapeutics Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Peptide Therapeutics Drugs Market Size Share by Application (2021-2026) Table 24. Global Peptide Therapeutics Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Peptide Therapeutics Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Peptide Therapeutics Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Peptide Therapeutics Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Peptide Therapeutics Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Peptide Therapeutics Drugs Industry Trends Table 37. Peptide Therapeutics Drugs Industry Drivers Table 38. Peptide Therapeutics Drugs Industry Opportunities and Challenges Table 39. Peptide Therapeutics Drugs Industry Restraints Table 40. Global Peptide Therapeutics Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Peptide Therapeutics Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Peptide Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Peptide Therapeutics Drugs Key Company Headquarters & Area Served Table 44. Global Peptide Therapeutics Drugs Company, Product Type & Application Table 45. Global Peptide Therapeutics Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Peptide Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Peptide Therapeutics Drugs Product Portfolio Table 52. Takeda Recent Development Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Peptide Therapeutics Drugs Product Portfolio Table 57. Teva Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Peptide Therapeutics Drugs Product Portfolio Table 62. Sanofi Recent Development Table 63. J & J Company Information Table 64. J & J Business Overview Table 65. J & J Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. J & J Peptide Therapeutics Drugs Product Portfolio Table 67. J & J Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Peptide Therapeutics Drugs Product Portfolio Table 72. Novartis Recent Development Table 73. Novo Nordisk Company Information Table 74. Novo Nordisk Business Overview Table 75. Novo Nordisk Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novo Nordisk Peptide Therapeutics Drugs Product Portfolio Table 77. Novo Nordisk Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck Peptide Therapeutics Drugs Product Portfolio Table 82. Merck Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eli Lilly Peptide Therapeutics Drugs Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Ferring Company Information Table 89. Ferring Business Overview Table 90. Ferring Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Ferring Peptide Therapeutics Drugs Product Portfolio Table 92. Ferring Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AbbVie Peptide Therapeutics Drugs Product Portfolio Table 97. AbbVie Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AstraZeneca Peptide Therapeutics Drugs Product Portfolio Table 102. AstraZeneca Recent Development Table 103. The Medicines Company Information Table 104. The Medicines Business Overview Table 105. The Medicines Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. The Medicines Peptide Therapeutics Drugs Product Portfolio Table 107. The Medicines Recent Development Table 108. Lantheus Company Information Table 109. Lantheus Business Overview Table 110. Lantheus Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Lantheus Peptide Therapeutics Drugs Product Portfolio Table 112. Lantheus Recent Development Table 113. Ipsen Company Information Table 114. Ipsen Business Overview Table 115. Ipsen Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Ipsen Peptide Therapeutics Drugs Product Portfolio Table 117. Ipsen Recent Development Table 118. CSL Vifor Group Company Information Table 119. CSL Vifor Group Business Overview Table 120. CSL Vifor Group Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. CSL Vifor Group Peptide Therapeutics Drugs Product Portfolio Table 122. CSL Vifor Group Recent Development Table 123. BioMarin Pharmaceutical Company Information Table 124. BioMarin Pharmaceutical Business Overview Table 125. BioMarin Pharmaceutical Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BioMarin Pharmaceutical Peptide Therapeutics Drugs Product Portfolio Table 127. BioMarin Pharmaceutical Recent Development Table 128. Aurinia Pharmaceuticals Company Information Table 129. Aurinia Pharmaceuticals Business Overview Table 130. Aurinia Pharmaceuticals Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Aurinia Pharmaceuticals Peptide Therapeutics Drugs Product Portfolio Table 132. Aurinia Pharmaceuticals Recent Development Table 133. Apellis Pharmaceuticals Company Information Table 134. Apellis Pharmaceuticals Business Overview Table 135. Apellis Pharmaceuticals Peptide Therapeutics Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Apellis Pharmaceuticals Peptide Therapeutics Drugs Product Portfolio Table 137. Apellis Pharmaceuticals Recent Development Table 138. North America Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Peptide Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Peptide Therapeutics Drugs Market Share by Country (2021-2026) Table 141. North America Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Peptide Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 143. Europe Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Peptide Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Peptide Therapeutics Drugs Market Share by Country (2021-2026) Table 146. Europe Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Peptide Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Peptide Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Peptide Therapeutics Drugs Market Share by Country (2021-2026) Table 151. Asia-Pacific Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Peptide Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 153. Latin America Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Peptide Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Peptide Therapeutics Drugs Market Share by Country (2021-2026) Table 156. Latin America Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Peptide Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2021-2026) Table 161. Middle East & Africa Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Peptide Therapeutics Drugs Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Peptide Therapeutics Drugs Product Image Figure 3. Global Peptide Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Peptide Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Peptide Therapeutics Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Peptide Therapeutics Drugs Market Share by Region (2021-2032) Figure 7. North America Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Injection Image Figure 13. Global Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Image Figure 15. Global Oral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Peptide Therapeutics Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Peptide Therapeutics Drugs Market Share by Type 2025 VS 2032 Figure 20. North America Peptide Therapeutics Drugs Market Size Share by Type (2021-2032) Figure 21. Europe Peptide Therapeutics Drugs Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Peptide Therapeutics Drugs Market Size Share by Type (2021-2032) Figure 23. Latin America Peptide Therapeutics Drugs Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Peptide Therapeutics Drugs Market Size Share by Type (2021-2032) Figure 25. Central Nervous System Image Figure 26. Global Central Nervous System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Metabolic Disorders Image Figure 28. Global Metabolic Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cancer Image Figure 30. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Peptide Therapeutics Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peptide Therapeutics Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Peptide Therapeutics Drugs Market Size Share by Application (2021-2032) Figure 36. Europe Peptide Therapeutics Drugs Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Peptide Therapeutics Drugs Market Size Share by Application (2021-2032) Figure 38. Latin America Peptide Therapeutics Drugs Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Peptide Therapeutics Drugs Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Peptide Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Peptide Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Peptide Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Peptide Therapeutics Drugs Market Share by Country (2021-2032) Figure 45. Europe Peptide Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peptide Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peptide Therapeutics Drugs Market Share by Country (2021-2032) Figure 48. Asia-Pacific Peptide Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Peptide Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Peptide Therapeutics Drugs Market Share by Country (2021-2032) Figure 51. Latin America Peptide Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Peptide Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peptide Therapeutics Drugs Market Share by Country (2021-2032) Figure 54. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
  • Other
Applications
  • Central Nervous System
  • Metabolic Disorders
  • Cancer
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • J & J
  • Novartis
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Ferring
  • AbbVie
  • AstraZeneca
  • The Medicines
  • Lantheus
  • Ipsen
  • CSL Vifor Group
  • BioMarin Pharmaceutical
  • Aurinia Pharmaceuticals
  • Apellis Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Peptide Therapeutics Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Peptide Therapeutics Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Peptide Therapeutics Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Peptide Therapeutics Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Peptide Therapeutics Drugs Market Size (2021-2032)
  8. 1.5.1 North America Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate (2021-2032)
2 Peptide Therapeutics Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Injection
  3. 2.1.2 Oral
  4. 2.1.3 Other
  5. 2.2 Global Peptide Therapeutics Drugs Market Size by Type
  6. 2.2.1 Global Peptide Therapeutics Drugs Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Peptide Therapeutics Drugs Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Peptide Therapeutics Drugs Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Peptide Therapeutics Drugs Market Size by Regions
  10. 2.3.1 North America Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Type (2021-2026)
3 Peptide Therapeutics Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Central Nervous System
  3. 3.1.2 Metabolic Disorders
  4. 3.1.3 Cancer
  5. 3.1.4 Other
  6. 3.2 Global Peptide Therapeutics Drugs Market Size by Application
  7. 3.2.1 Global Peptide Therapeutics Drugs Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Peptide Therapeutics Drugs Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Peptide Therapeutics Drugs Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Peptide Therapeutics Drugs Market Size by Regions
  11. 3.3.1 North America Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Peptide Therapeutics Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Peptide Therapeutics Drugs Industry Trends
  2. 4.2 Peptide Therapeutics Drugs Industry Drivers
  3. 4.3 Peptide Therapeutics Drugs Industry Opportunities and Challenges
  4. 4.4 Peptide Therapeutics Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Peptide Therapeutics Drugs Revenue (2021-2026)
  2. 5.2 Global Peptide Therapeutics Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Peptide Therapeutics Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Peptide Therapeutics Drugs Company, Product Type & Application
  5. 5.5 Global Peptide Therapeutics Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Peptide Therapeutics Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Peptide Therapeutics Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Peptide Therapeutics Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Peptide Therapeutics Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Peptide Therapeutics Drugs Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Peptide Therapeutics Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 J & J
  20. 6.4.1 J & J Company Information
  21. 6.4.2 J & J Business Overview
  22. 6.4.3 J & J Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 J & J Peptide Therapeutics Drugs Product Portfolio
  24. 6.4.5 J & J Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Peptide Therapeutics Drugs Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Novo Nordisk
  32. 6.6.1 Novo Nordisk Company Information
  33. 6.6.2 Novo Nordisk Business Overview
  34. 6.6.3 Novo Nordisk Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novo Nordisk Peptide Therapeutics Drugs Product Portfolio
  36. 6.6.5 Novo Nordisk Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck Peptide Therapeutics Drugs Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Peptide Therapeutics Drugs Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Ferring
  50. 6.9.1 Ferring Company Information
  51. 6.9.2 Ferring Business Overview
  52. 6.9.3 Ferring Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Ferring Peptide Therapeutics Drugs Product Portfolio
  54. 6.9.5 Ferring Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Peptide Therapeutics Drugs Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AstraZeneca Peptide Therapeutics Drugs Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 The Medicines
  68. 6.12.1 The Medicines Company Information
  69. 6.12.2 The Medicines Business Overview
  70. 6.12.3 The Medicines Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 The Medicines Peptide Therapeutics Drugs Product Portfolio
  72. 6.12.5 The Medicines Recent Developments
  73. 6.13 Lantheus
  74. 6.13.1 Lantheus Company Information
  75. 6.13.2 Lantheus Business Overview
  76. 6.13.3 Lantheus Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Lantheus Peptide Therapeutics Drugs Product Portfolio
  78. 6.13.5 Lantheus Recent Developments
  79. 6.14 Ipsen
  80. 6.14.1 Ipsen Company Information
  81. 6.14.2 Ipsen Business Overview
  82. 6.14.3 Ipsen Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Ipsen Peptide Therapeutics Drugs Product Portfolio
  84. 6.14.5 Ipsen Recent Developments
  85. 6.15 CSL Vifor Group
  86. 6.15.1 CSL Vifor Group Company Information
  87. 6.15.2 CSL Vifor Group Business Overview
  88. 6.15.3 CSL Vifor Group Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 CSL Vifor Group Peptide Therapeutics Drugs Product Portfolio
  90. 6.15.5 CSL Vifor Group Recent Developments
  91. 6.16 BioMarin Pharmaceutical
  92. 6.16.1 BioMarin Pharmaceutical Company Information
  93. 6.16.2 BioMarin Pharmaceutical Business Overview
  94. 6.16.3 BioMarin Pharmaceutical Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BioMarin Pharmaceutical Peptide Therapeutics Drugs Product Portfolio
  96. 6.16.5 BioMarin Pharmaceutical Recent Developments
  97. 6.17 Aurinia Pharmaceuticals
  98. 6.17.1 Aurinia Pharmaceuticals Company Information
  99. 6.17.2 Aurinia Pharmaceuticals Business Overview
  100. 6.17.3 Aurinia Pharmaceuticals Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Aurinia Pharmaceuticals Peptide Therapeutics Drugs Product Portfolio
  102. 6.17.5 Aurinia Pharmaceuticals Recent Developments
  103. 6.18 Apellis Pharmaceuticals
  104. 6.18.1 Apellis Pharmaceuticals Company Information
  105. 6.18.2 Apellis Pharmaceuticals Business Overview
  106. 6.18.3 Apellis Pharmaceuticals Peptide Therapeutics Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Apellis Pharmaceuticals Peptide Therapeutics Drugs Product Portfolio
  108. 6.18.5 Apellis Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Peptide Therapeutics Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Peptide Therapeutics Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Peptide Therapeutics Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Peptide Therapeutics Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst